Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells

Ting Yu Qu, Xia Jing Dong, Ikuko Sugaya, Ankur Vaghani, Jose S Pulido, Kiminobu Sugaya

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Purpose: Recent reports show that marrow derived mesenchymal stem cells (MeSCs) may have the ability to differentiate into diverse cell types unrelated to their phenotypical embryonic origin, including neural cells. While demonstrated "in vitro" and neonatally, efforts to demonstrate this ability in adult animal brains have had limited success. If it can be shown that human MeSC (HMeSC) can differentiate into neural cells in adult brain, it would open up the possibility that HMeSCs may be of potential therapeutic use in cell replacement therapies for neurological diseases. Here, we demonstrate that adult HMeSCs treated with 5-bromo-2-deoxyuridine (BrdU) for 3 weeks develop the capability to differentiate into neural and retinal cells when provided the appropriate lineage specific differentiation signals in vitro and in adult animals. HMeSC without BrdU treatment did not differentiate into neurons in vitro or adult animal or retinal cells in adult animal. Methods: MeSCs isolated from adult human bone marrow were treated with BrdU (3 μM) for 3 weeks and then subjected to differentiation conditions both in vitro and in vivo. Results: BrdU pretreated HMeSCs express neuronal and glial markers after co-culture with differentiated human neural stem cells and after transplantation into the adult rat brain. HMeSCs pretreated with BrdU and transforming growth factor-β3 express a photoreceptor marker after transplantation into the adult rat vitreous. Conclusions: These results suggest that BrdU treatment may increase the multipotency of HMeSCs for possible use in autologous cell therapies for neurological and opthamological diseases. 2004 - IOS Press and the authors. All rights reserved.

Original languageEnglish (US)
Pages (from-to)459-468
Number of pages10
JournalRestorative Neurology and Neuroscience
Volume22
Issue number6
StatePublished - 2004
Externally publishedYes

Fingerprint

Bromodeoxyuridine
Deoxyuridine
Stem Cells
Bone Marrow
Mesenchymal Stromal Cells
Cell- and Tissue-Based Therapy
Brain
Neural Stem Cells
Transforming Growth Factors
Stem Cell Transplantation
Therapeutic Uses
Coculture Techniques
Neuroglia
Transplantation
Neurons
In Vitro Techniques
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology

Cite this

Qu, T. Y., Dong, X. J., Sugaya, I., Vaghani, A., Pulido, J. S., & Sugaya, K. (2004). Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells. Restorative Neurology and Neuroscience, 22(6), 459-468.

Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells. / Qu, Ting Yu; Dong, Xia Jing; Sugaya, Ikuko; Vaghani, Ankur; Pulido, Jose S; Sugaya, Kiminobu.

In: Restorative Neurology and Neuroscience, Vol. 22, No. 6, 2004, p. 459-468.

Research output: Contribution to journalArticle

Qu, TY, Dong, XJ, Sugaya, I, Vaghani, A, Pulido, JS & Sugaya, K 2004, 'Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells', Restorative Neurology and Neuroscience, vol. 22, no. 6, pp. 459-468.
Qu, Ting Yu ; Dong, Xia Jing ; Sugaya, Ikuko ; Vaghani, Ankur ; Pulido, Jose S ; Sugaya, Kiminobu. / Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells. In: Restorative Neurology and Neuroscience. 2004 ; Vol. 22, No. 6. pp. 459-468.
@article{82dabe3f44ab465a935d805870884dc4,
title = "Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells",
abstract = "Purpose: Recent reports show that marrow derived mesenchymal stem cells (MeSCs) may have the ability to differentiate into diverse cell types unrelated to their phenotypical embryonic origin, including neural cells. While demonstrated {"}in vitro{"} and neonatally, efforts to demonstrate this ability in adult animal brains have had limited success. If it can be shown that human MeSC (HMeSC) can differentiate into neural cells in adult brain, it would open up the possibility that HMeSCs may be of potential therapeutic use in cell replacement therapies for neurological diseases. Here, we demonstrate that adult HMeSCs treated with 5-bromo-2-deoxyuridine (BrdU) for 3 weeks develop the capability to differentiate into neural and retinal cells when provided the appropriate lineage specific differentiation signals in vitro and in adult animals. HMeSC without BrdU treatment did not differentiate into neurons in vitro or adult animal or retinal cells in adult animal. Methods: MeSCs isolated from adult human bone marrow were treated with BrdU (3 μM) for 3 weeks and then subjected to differentiation conditions both in vitro and in vivo. Results: BrdU pretreated HMeSCs express neuronal and glial markers after co-culture with differentiated human neural stem cells and after transplantation into the adult rat brain. HMeSCs pretreated with BrdU and transforming growth factor-β3 express a photoreceptor marker after transplantation into the adult rat vitreous. Conclusions: These results suggest that BrdU treatment may increase the multipotency of HMeSCs for possible use in autologous cell therapies for neurological and opthamological diseases. 2004 - IOS Press and the authors. All rights reserved.",
author = "Qu, {Ting Yu} and Dong, {Xia Jing} and Ikuko Sugaya and Ankur Vaghani and Pulido, {Jose S} and Kiminobu Sugaya",
year = "2004",
language = "English (US)",
volume = "22",
pages = "459--468",
journal = "Restorative Neurology and Neuroscience",
issn = "0922-6028",
publisher = "IOS Press",
number = "6",

}

TY - JOUR

T1 - Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells

AU - Qu, Ting Yu

AU - Dong, Xia Jing

AU - Sugaya, Ikuko

AU - Vaghani, Ankur

AU - Pulido, Jose S

AU - Sugaya, Kiminobu

PY - 2004

Y1 - 2004

N2 - Purpose: Recent reports show that marrow derived mesenchymal stem cells (MeSCs) may have the ability to differentiate into diverse cell types unrelated to their phenotypical embryonic origin, including neural cells. While demonstrated "in vitro" and neonatally, efforts to demonstrate this ability in adult animal brains have had limited success. If it can be shown that human MeSC (HMeSC) can differentiate into neural cells in adult brain, it would open up the possibility that HMeSCs may be of potential therapeutic use in cell replacement therapies for neurological diseases. Here, we demonstrate that adult HMeSCs treated with 5-bromo-2-deoxyuridine (BrdU) for 3 weeks develop the capability to differentiate into neural and retinal cells when provided the appropriate lineage specific differentiation signals in vitro and in adult animals. HMeSC without BrdU treatment did not differentiate into neurons in vitro or adult animal or retinal cells in adult animal. Methods: MeSCs isolated from adult human bone marrow were treated with BrdU (3 μM) for 3 weeks and then subjected to differentiation conditions both in vitro and in vivo. Results: BrdU pretreated HMeSCs express neuronal and glial markers after co-culture with differentiated human neural stem cells and after transplantation into the adult rat brain. HMeSCs pretreated with BrdU and transforming growth factor-β3 express a photoreceptor marker after transplantation into the adult rat vitreous. Conclusions: These results suggest that BrdU treatment may increase the multipotency of HMeSCs for possible use in autologous cell therapies for neurological and opthamological diseases. 2004 - IOS Press and the authors. All rights reserved.

AB - Purpose: Recent reports show that marrow derived mesenchymal stem cells (MeSCs) may have the ability to differentiate into diverse cell types unrelated to their phenotypical embryonic origin, including neural cells. While demonstrated "in vitro" and neonatally, efforts to demonstrate this ability in adult animal brains have had limited success. If it can be shown that human MeSC (HMeSC) can differentiate into neural cells in adult brain, it would open up the possibility that HMeSCs may be of potential therapeutic use in cell replacement therapies for neurological diseases. Here, we demonstrate that adult HMeSCs treated with 5-bromo-2-deoxyuridine (BrdU) for 3 weeks develop the capability to differentiate into neural and retinal cells when provided the appropriate lineage specific differentiation signals in vitro and in adult animals. HMeSC without BrdU treatment did not differentiate into neurons in vitro or adult animal or retinal cells in adult animal. Methods: MeSCs isolated from adult human bone marrow were treated with BrdU (3 μM) for 3 weeks and then subjected to differentiation conditions both in vitro and in vivo. Results: BrdU pretreated HMeSCs express neuronal and glial markers after co-culture with differentiated human neural stem cells and after transplantation into the adult rat brain. HMeSCs pretreated with BrdU and transforming growth factor-β3 express a photoreceptor marker after transplantation into the adult rat vitreous. Conclusions: These results suggest that BrdU treatment may increase the multipotency of HMeSCs for possible use in autologous cell therapies for neurological and opthamological diseases. 2004 - IOS Press and the authors. All rights reserved.

UR - http://www.scopus.com/inward/record.url?scp=17244373506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17244373506&partnerID=8YFLogxK

M3 - Article

C2 - 15798364

AN - SCOPUS:17244373506

VL - 22

SP - 459

EP - 468

JO - Restorative Neurology and Neuroscience

JF - Restorative Neurology and Neuroscience

SN - 0922-6028

IS - 6

ER -